Works matching IS 00099236 AND DT 2025 AND VI 117 AND IP 2

Results: 35
    1

    Highlighted Articles.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 324, doi. 10.1002/cpt.3523
    Publication type:
    Article
    2

    ASCPT News.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 326, doi. 10.1002/cpt.3522
    Publication type:
    Article
    3
    4

    In this Issue.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 319, doi. 10.1002/cpt.3519
    Publication type:
    Article
    5
    6

    French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 387, doi. 10.1002/cpt.3502
    By:
    • Lebreton, Louis;
    • Boyer, Jean‐Christophe;
    • Lafay‐Chebassier, Claire;
    • Hennart, Benjamin;
    • Baklouti, Sarah;
    • Cunat, Séverine;
    • Vilquin, Paul;
    • Medard, Yves;
    • Gautier‐Veyret, Elodie;
    • Laffitte‐Redondo, Clara;
    • Verstuyft, Céline;
    • Ait Tayeb, Abd El Kader;
    • Haufroid, Vincent;
    • Wils, Julien;
    • Lamoureux, Fabien;
    • Evrard, Alexandre;
    • Davaze‐Schneider, Julie;
    • Ben‐Sassi, Mouna;
    • Picard, Nicolas;
    • Quaranta, Sylvie
    Publication type:
    Article
    7
    8
    9
    10

    Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 335, doi. 10.1002/cpt.3494
    By:
    • Correia Pinheiro, Luis;
    • Arlett, Peter;
    • Roes, Kit;
    • Musuamba Tshinanu, Flora;
    • Westman, Gabriel;
    • Frias, Zaide;
    • Hamann, Hilmar;
    • Berenguer Jornet, Joaquim;
    • Khan, Iftekhar;
    • Larsen, Jeppe;
    • Broich, Karl;
    • Cooke, Emer
    Publication type:
    Article
    11
    12
    13
    14
    15

    Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 523, doi. 10.1002/cpt.3482
    By:
    • Koishikawa, Tomoki;
    • Fujiwara, Kaku;
    • Taskar, Kunal;
    • Zamek‐Gliszczynski, Maciej J.;
    • Yoshida, Kenta;
    • Chu, Xiaoyan;
    • Hirabayashi, Hideki;
    • Mao, Jialin;
    • Rockich, Kevin;
    • Takashima, Tadayuki;
    • Yamaura, Yoshiyuki;
    • Lai, Yurong;
    • Tomoda, Yukana;
    • Kito, Tomoko;
    • Maeda, Kazuya;
    • Furihata, Kenichi;
    • Sugiyama, Yuichi;
    • Kusuhara, Hiroyuki
    Publication type:
    Article
    16
    17
    18
    19

    Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 403, doi. 10.1002/cpt.3477
    By:
    • Reddy, Micaela B.;
    • Cabalu, Tamara D.;
    • de Zwart, Loeckie;
    • Ramsden, Diane;
    • Dowty, Martin E.;
    • Taskar, Kunal S.;
    • Badée, Justine;
    • Bolleddula, Jayaprakasam;
    • Boulu, Laurent;
    • Fu, Qiang;
    • Kotsuma, Masakatsu;
    • Leblanc, Alix F.;
    • Lewis, Gareth;
    • Liang, Guiqing;
    • Parrott, Neil;
    • Pilla Reddy, Venkatesh;
    • Prakash, Chandra;
    • Shah, Kushal;
    • Umehara, Kenichi;
    • Mukherjee, Dwaipayan
    Publication type:
    Article
    20
    21

    Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 506, doi. 10.1002/cpt.3471
    By:
    • Mwebaza, Norah;
    • Roh, Michelle E.;
    • Geng, Yourong Z.;
    • Opio, Leonard;
    • Opira, Bishop;
    • Marzan, Florence;
    • Mwima, Moses W.;
    • Ssemukuye, Timothy;
    • Guo, Kevin;
    • Gingrich, David;
    • Fotaki, Nikoletta;
    • Kakuru, Abel;
    • Kizza, Jimmy;
    • Aguti, Miriam;
    • Adrama, Harriet;
    • Kamya, Moses;
    • Dorsey, Grant;
    • Rosenthal, Philip J.;
    • Aweeka, Francesca T.;
    • Huang, Liusheng
    Publication type:
    Article
    22
    23
    24
    25

    Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 475, doi. 10.1002/cpt.3464
    By:
    • Pisal, Dipak S.;
    • Li, Yangbing;
    • Golding, Amit;
    • Nair, Raj;
    • Nikolov, Nikolay P.;
    • Madabushi, Rajanikanth;
    • Zhu, Hao;
    • Doddapaneni, Suresh;
    • Sahajwalla, Chandrahas;
    • Bi, Youwei;
    • Chen, Jianmeng
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 465, doi. 10.1002/cpt.3445
    By:
    • Li, Chi‐Chung;
    • Bender, Brendan;
    • Wilkins, Justin;
    • Li, Feifei;
    • Turner, David C.;
    • Wang, Bei;
    • Deng, Rong;
    • Vadhavkar, Shweta;
    • Li, Zao;
    • Kwan, Antonia;
    • Huang, Huang;
    • Peng, Kun;
    • Penuel, Elicia;
    • Huw, Ling‐Yuh;
    • Chanu, Pascal;
    • Li, Chunze;
    • Yin, Shen;
    • Wei, Michael C.
    Publication type:
    Article
    33
    34
    35

    Issue Information.

    Published in:
    Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 311, doi. 10.1002/cpt.3318
    Publication type:
    Article